Doxazosin
NDC 0832-0356, Doxazosin Mesylate, tablet, from Upsher-Smith laboratories, LLC.
- Product NDC
- 0832-0356
- Status
- Listed
- Labeler
- Upsher-Smith laboratories, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209013
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0832-0356 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXAZOSIN MESYLATE1 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0832-0356-11 | 00832035611 | 100 TABLET in 1 BOTTLE (0832-0356-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b5d1c604-ce3b-4973-845f-9db267a945cdNADAC price for package 00832035611
GET /v1/drugs/nadac/00832035611
Use it
Look up 0832-0356 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0832-0356 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0832-0356. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.